Get started
Author

Anka Postic

Observed names: A. Postic, Anka Poštić
ORCID: 0009-0009-8210-7744
Observed ORCID: 0009-0009-8210-7744
OpenAlex ID: A5035666085
Utility of neutrophil to lymphocyte ratio in the prediction of inflammation and COPD mortality
2025 · Sanja Dimic-Janjic, Andrej Zecevic, et al. · The Journal of Infection in Developing Countries · 3
PDF
Comparison of the Efficacy of Pirfenidone and Nintedanib in the Treatment of Patients with Idiopathic Pulmonary Fibrosis—A Single-Center Experience
2026 · Nikola Trboljevac, Sanja Dimic-Janjic, et al. · Medicina · 1
PDF
Characteristics of Patients With Post-COVID-19 Pulmonary Embolism
2023 · B.A. Milenkovic, D. Vukosavljevic, et al. · American Journal of Respiratory and Critical Care Medicine · 1
Prognostic factors in elderly patients with acute myeloid leukemia
2021 · Anka Poštić, Marijana Virijević · Srpski medicinski casopis Lekarske komore · 1
PDF
Early Functional Impairment in Smokers with CT-Detected Emphysema: Spirometry Provides Complementary Physiological Information in Lung Cancer Screening
2026 · Sanja Dimic-Janjic, Ivana Buha, et al. · Biomedicines
PDF
Laboratory findings as prognostic factors of progression-free survival and overall survival in patients with stage IV lung adenocarcinoma
2025 · Andrej Zecevic, Branislav Ilic, et al. · European Respiratory Journal
Works count: 6
Citation count: 6
H-index: 1
I10-index:
Year
Topic
Type